In-Person Access Only | 1.75 CE/CME Credits

The Cancer Updates Conference will consist of educational activities designed to meet the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of GU cancers and hematological malignancies. Each agenda is comprised of presentations that will break down the most clinically relevant information applicable to community care. This dinner program will be hosted as an in-person event only.

Conference Agenda
Thursday, December 4, 2025

5:00 PM
Networking and Cocktails

5:30 PM
Welcome and Opening Remarks
Erin Schwab, MD | Vail Health (Program Co-Chair)
Jeffrey Matous, MD | Colorado Blood Cancer Institute (Program Co-Chair)

5:35 PM
GU Cancer Updates 
Erin Schwab, MD | Vail Health (Program Co-Chair)

6:05 PM
GU Fireside Chat
Moderator: Erin Schwab, MD | Vail Health (Program Co-Chair)
Laura Graham, MD | UCHealth
Manojkumar Bupathi, MD | Rocky Mountain Cancer Centers

6:25 PM
Dinner and Exhibits

6:40 PM
Non CME Session - Pfizer - Getting Started & Transitioning to Outpatient Care for Patients With Relapsed or Refractory Multiple Myeloma
Aaron Goodman, MD | Sarah Cannon Transplant and Cellular Therapy Las Vegas

7:25 PM
Hematology Cancer Updates
Jeffrey Matous, MD | Colorado Blood Cancer Institute (Program Co-Chair)

7:55 PM
Hematology Fireside Chat
Moderator: Jeffrey Matous, MD | Colorado Blood Cancer Institute (Program Co-Chair)
Tara Gregory, MD | Colorado Blood Cancer Institute
Daniel Sherbenou, MD, PhD | University of Colorado Cancer Center

8:15 PM
Adjourn

Agenda Subject To Change. All times are MST.

• Learning Objectives

  • Review recent clinical advances in the treatment of gastrointestinal (GI) and breast cancers, with a focus on the most relevant data from recent studies and clinical trials.

  • Evaluate the role of emerging therapies in GI and breast cancer treatment, including new medications, targeted therapies, and immunotherapies.

  • Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.

  • Assess and manage side effects and toxicities associated with current and emerging therapies in GI and breast cancer patients.

  • Discuss multidisciplinary care approaches that enhance collaboration between oncologists, pharmacists, nurses, and advanced practitioners in treating GI and breast cancers.

• Accreditation Information | 1.75 CE/CME Credits

  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Nurses (ANCC) Credit Designation

  Amedco LLC designates this activity for a maximum of 1.75 ANCC contact hours.

  Physicians (ACCME) Credit Designation

  Amedco LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

  Amedco LLC designates this activity for a maximum of 1.75 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

• What to Expect | In-Person Learners

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources